Showing results (11-20 of 174) with videos related to
Sort By:
Pageof 18
Journal of Thoracic Disease|October 29, 2013
Targeted therapy in lung cancer: IPASS and beyond, keeping abreast of the explosion of targeted therapies for lung cancerPeter Savas, Brett Hughes, Benjamin SolomonJournal of Immunotherapy (Hagerstown, Md. : 1997)|July 3, 2018
Complete and Prolonged Response of Renal Cell Carcinoma With Rhabdoid Features to Checkpoint Inhibitor TherapyEmily Wynja, Benjamin Solomon, Jonathan BleekerJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 6, 2019
First-line pembrolizumab therapy in a cisplatin-ineligible patient with plasmacytoid urothelial carcinoma: A case reportLindsay Hunter, Justin Moser, Caleb Sturge, et al.Medical Care|March 14, 2015
Women with breast cancer in the Veterans Health Administration: demographics, breast cancer characteristics, and trendsSarah Colonna, Ahmad Halwani, Jian Ying, et al.Seminars in Cancer Biology|January 23, 2018
Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatmentsBenjamin Solomon, Richard J Young, Danny RischinJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2009
ALK gene rearrangements: a new therapeutic target in a molecularly defined subset of non-small cell lung cancerBenjamin Solomon, Marileila Varella-Garcia, D Ross CamidgeOncology (Williston Park, N.Y.)|January 24, 2006
Adjuvant chemotherapy for resected non-small-cell lung cancerBenjamin Solomon, John D Mitchell, Paul A BunnJournal of Personalized Medicine|January 7, 2015
Molecular therapeutic advances in personalized therapy of melanoma and non-small cell lung cancerFergal C Kelleher, Benjamin Solomon, Grant A McArthurAsia-Pacific Journal of Clinical Oncology|September 3, 2011
The emerging era of personalized therapy in squamous cell carcinoma of the head and neckDavid I Pryor, Benjamin Solomon, Sandro V PorcedduJournal of the National Comprehensive Cancer Network : JNCCN|December 14, 2011
Crizotinib and testing for ALKAlice T Shaw, Benjamin Solomon, Mari Mino KenudsonPageof 18